相关实验视频
Updated: Jul 20, 2025

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.4K
作为对SARS-CoV-2主要蛋白酶的潜在抑制剂的geranin的无效化
Rui Zhang1, Haohao Yan1, Jiahao Zhou1
1Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, P. R. China.
Natural product research
|August 3, 2023
概括
格拉尼因被调查为一种潜在的抗病毒药物用于COVID-19治疗. 严格的体外测试表明,格拉尼因不抑制SARS-CoV-2主要蛋白酶 (Mpro),强调需要仔细验证.
科学领域:
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
- 病毒学 病毒学
背景情况:
- 最近,Geraniin被确定为一种潜在的抗病毒药物,向SARS-CoV-2主要蛋白酶 (Mpro).
- 进一步验证至关重要,以确认geranin在COVID-19治疗中的有效性.
- 需要严格地在体外评估杰拉宁的Mpro抑制活性.
研究的目的:
- 严格评估格拉尼因对SARS-CoV-2的体外抑制作用 Mpro.
- 为了验证或驳斥杰拉宁作为Mpro抑制剂的潜力.
- 强调在Mpro抑制剂发现中严格验证的重要性.
主要方法:
- 使用光共振能量转移 (FRET) 试验.
- 采用光极化 (FP) 试验.
- 应用二分化依赖的红色光蛋白 (ddRFP) 试验.
主要成果:
- 格兰尼在体外没有对SARS-CoV-2 Mpro表现出显著的抑制作用.
- 来自FRET,FP和ddRFP测定的结果始终表明基拉尼因缺乏Mpro抑制.
- 通过天然产品灭光被确定为潜在的混因素.
结论:
- 根据目前的体外研究结果,Geraniin不是一种可行的Mpro抑制剂.
- 多种生物化学测试对于严格验证潜在的Mpro抑制剂至关重要.
- 研究人员在评估天然产品作为Mpro抑制剂时,必须考虑光灭效应.
更多相关视频
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
33.3K
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
相关概念视频
Enzyme Inhibition
78.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.7K
Antimicrobial Effectiveness
48
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
48
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K